STERIS plc (Ireland) Ordinary Shares (STE)

DUBLIN, IRELAND, Feb. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 third quarter ended December 31, 2024. Total revenue from continuing operations for the third quarter of fiscal 2025 increased 6% to $1.4 billion compared with $1.3 billion in the third quarter of fiscal 2024. Constant currency organic revenue from continuing operations for the third quarter also increased 6%.

DUBLIN, IRELAND, Jan. 28, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on March 21, 2025, to shareholders of record at the close of business on February 20, 2025.  

DUBLIN, IRELAND , Jan. 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 third quarter financial results at 9:00 a.m. ET on February 6, 2025. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.

DUBLIN, IRELAND, Jan. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced that a jury trial that had been ongoing since December 4, 2024, against Isomedix Operations, Inc. (“Isomedix”), a subsidiary of the Company, ended in a mistrial on January 17, 2025.

DUBLIN, IRELAND, Nov. 06, 2024 (GLOBE NEWSWIRE) --  - STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. Total revenue from continuing operations for the second quarter of fiscal 2025 increased 7% to $1.3 billion compared with $1.2 billion in the second quarter of fiscal 2024. Constant currency organic revenue from continuing operations for the second quarter increased 7%.

DUBLIN, IRELAND, Oct. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on December 19, 2024, to shareholders of record at the close of business on November 19, 2024.  

DUBLIN, IRELAND, Oct. 23, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 second quarter financial results at 9:00 a.m. ET on November 7, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  

DUBLIN, IRELAND, Aug. 26, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 4, 2024. Dan Carestio, President and CEO of STERIS will present at 1:50 p.m. Eastern Time.

DUBLIN, IRELAND , Aug. 06, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 first quarter ended June 30, 2024. Total revenue from continuing operations for the first quarter of fiscal 2025 increased 8% to $1.3 billion compared with $1.2 billion in the first quarter of fiscal 2024. Constant currency organic revenue from continuing operations for the first quarter increased 6%.

DUBLIN, IRELAND, July 31, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. This represents a $0.05 increase in the dividend and the Company’s 19th consecutive year of dividend growth. The dividend is payable on September 20, 2024, to shareholders of record at the close of business on September 5, 2024.  

DUBLIN, IRELAND, July 23, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 first quarter financial results at 9:00 a.m. ET on August 7, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  

DUBLIN, IRELAND , May 08, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024. Total revenue for the fourth quarter of fiscal 2024 increased 10% to $1.5 billion compared with $1.4 billion in the fourth quarter of fiscal 2023. Constant currency organic revenue from continuing operations for the fourth quarter increased 7% to $1.4 billion compared with $1.3 billion in the fourth quarter of fiscal 2023.

DUBLIN, IRELAND, May 01, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on June 26, 2024, to shareholders of record at the close of business on June 12, 2024.

DUBLIN, IRELAND, April 24, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  

DUBLIN, IRELAND, April 11, 2024 (GLOBE NEWSWIRE) -- ) - STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced that the Company has entered into a definitive agreement to divest its Dental segment to Peak Rock Capital, a leading middle-market private investment firm, for $787.5 million (the “Transaction”). The Transaction is structured as an equity sale. The Transaction terms also include the opportunity for STERIS to receive an additional earnout of up to $12.5 million, subject to the achievement of certain revenue targets of the Dental segment in fiscal 2025. The Dental segment reported revenue of $407 million and contributed segment operating income of $86 million in the trailing twelve-month period ended December 31, 2023.

DUBLIN, IRELAND, Feb. 07, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 third quarter ended December 31, 2023. Revenue as reported for the quarter increased 15% to $1.40 billion compared with $1.22 billion in the third quarter of fiscal 2023. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 10% for the third quarter of fiscal 2024 as compared to the third quarter of fiscal 2023.  

DUBLIN, IRELAND , Jan. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on March 22, 2024, to shareholders of record at the close of business on February 23, 2024.

DUBLIN, IRELAND, Jan. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 third quarter financial results at 9:00 a.m. ET on February 8, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  

DUBLIN, IRELAND, Nov. 07, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 second quarter ended September 30, 2023. Revenue as reported for the quarter increased 12% to $1.34 billion compared with $1.20 billion in the second quarter of fiscal 2023. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 8% for the second quarter of fiscal 2024 as compared to the second quarter of fiscal 2023.  

DUBLIN, IRELAND, Oct. 31, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on December 21, 2023, to shareholders of record at the close of business on November 21, 2023.  

DUBLIN, IRELAND, Oct. 24, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 second quarter financial results at 9:00 a.m. ET on November 8, 2023. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.  

DUBLIN, IRELAND , Aug. 30, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 13, 2023.   Dan Carestio, President and CEO of STERIS will present at 8:10 a.m. Eastern Time.

DUBLIN, IRELAND, Aug. 02, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from BD (Becton, Dickinson and Company) NYSE:BDXNYSEBDX)

DUBLIN, IRELAND, Aug. 01, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSESTE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 first quarter ended June 30, 2023. Revenue as reported for the quarter increased 11% to $1.28 billion compared with $1.16 billion in the first quarter of fiscal 2023. Constant currency organic revenue (see Non-GAAP Financial Measures) also increased 11% for the first quarter of fiscal 2024 as compared to the first quarter of fiscal 2023.  

DUBLIN, IRELAND , July 26, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSESTE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. This represents a $0.05 increase in the dividend and the Company’s 18th consecutive year of dividend growth. The dividend is payable on September 22, 2023, to shareholders of record at the close of business on September 6, 2023.